EGFR-AS1 - EGFR antisense RNA 1 Gene

Species: Homo sapiens

Gene Type: ncRNA
Gene ID: 100507500

About EGFR-AS1

This gene has 1 transcript (splice variant). Broad expression in placenta (RPKM 4.4), small intestine (RPKM 1.8) and 18 other tissues.

Related Diseases

Diseases Alias
Lung Cancer

  • Lung Carcinoma

  • Non-Small Cell Lung Carcinoma

  • Lung Cancer, Susceptibility To

  • Lung Cancer, Protection Against

  • Adenocarcinoma Of Lung, Somatic

  • Adenocarcinoma Of Lung, Response To Tyrosine Kinase Inhibitor In

  • Nonsmall Cell Lung Cancer

  • Lung Neoplasm

  • Carcinoma Of Lung

  • Lung Non-Small Cell Carcinoma

  • Non-Small Cell Lung Cancer

  • Nsclc

  • Lung Neoplasms

  • Malignant Neoplasm Of Lung

  • Alveolar Cell Carcinoma

  • Nonsmall Cell Lung Cancer, Somatic

  • Nonsmall Cell Lung Cancer, Response To Tyrosine Kinase Inhibitor In

  • Nonsmall Cell Lung Cancer, Susceptibility To

  • Lung Cancer, Somatic

  • Lung Cancer, Resistance To

  • Cancer Of Lung

  • Cancer Of Bronchus

  • Cancer Of The Lung

  • Lung Malignancies

  • Lung Malignant Tumors

  • Malignant Lung Tumor

  • Malignant Tumor Of Lung

  • Pulmonary Cancer

  • Pulmonary Carcinoma

  • Pulmonary Neoplasms

  • Respiratory Carcinoma

  • LNCR

  • Adenocarcinoma Of Lung

  • Neoplasm Of Lung

  • Cancer Lung

  • Carcinoma Non-Small Cell Lung

  • Carcinoma, Non-Small-Cell Lung

  • Lung Cancers

  • Lung Carcinomas

  • Cancer, Lung

  • Cancer, Lung, Non-Small Cell

  • Primary Malignant Neoplasm Of Lung

  • Bronchioloalveolar Adenocarcinoma
Osteogenic Sarcoma

  • Osteosarcoma

  • OSRC

  • Osteosarcoma, Somatic

  • Neoplasms, Bone Tissue

  • Bone Tissue Neoplasm

  • Osteoid Sarcoma

  • Skeletal Sarcoma

  • Osteosarcoma Of Bone

  • Bone Sarcoma
Hepatocellular Carcinoma

  • Liver Cancer

  • Primary Liver Cancer

  • HCC

  • Hepatoma

  • Malignant Neoplasm Of Liver

  • Liver Neoplasms

  • Cancer, Hepatocellular

  • Liver Cell Carcinoma

  • Lcc

  • Hepatoblastoma, Somatic

  • Hepatic Cancer

  • Primary Malignant Neoplasm Of Liver

  • Rare Tumor Of Liver And Intrahepatic Biliary Tract

  • Hepatocellular Carcinoma, Somatic

  • Hepatocellular Carcinoma, Childhood Type, Somatic

  • Hepatocellular Cancer, Somatic

  • Ca Liver - Primary

  • Hepatic Neoplasm

  • Malignant Hepato-Biliary Neoplasm

  • Malignant Neoplasm Of Liver, Not Specified As Primary Or Secondary

  • Malignant Neoplasm Of Liver, Primary

  • Malignant Tumor Of Liver

  • Neoplasm Of Liver

  • Non-Resectable Primary Hepatic Malignant Neoplasm

  • Resectable Malignant Neoplasm Of Liver

  • Resectable Malignant Neoplasm Of The Liver

  • Primary Liver Carcinoma

  • Primary Malignant Liver Neoplasm

  • Primary Cancer Of Liver

  • Primary Tumor Of The Liver

  • Rare Tumor Of Liver And Ibt

  • Hepatocellular Cancer

  • Neoplasm Of The Liver

  • Carcinoma, Hepatocellular

  • Hepatomas

  • Liver Neoplasm

  • Liver Carcinoma

  • Liver And Intrahepatic Biliary Tract Carcinoma

  • Malignant Hepatobiliary Neoplasm

  • Adult Primary Hepatocellular Carcinoma

  • Hepatoblastoma

  • Carcinoma Of Liver

  • Malignant Liver Tumour

  • Malignant Hepatic Tumour
Squamous Cell Carcinoma

  • Epidermoid Carcinoma

  • Squamous Cell Cancer

  • Carcinoma, Squamous Cell

  • Squamous Cell Skin Cancer

  • Malignant Squamous Cell Tumor

  • Squamous Carcinoma

  • Squamous Cell Epithelioma

  • Carcinoma Squamous Cell

  • Neoplasms, Squamous Cell

  • Squamous Cell Carcinoma - Category

  • Malignant Squamous Cell Neoplasm

  • Squamous Cell Carcinoma Of Skin
Lung Squamous Cell Carcinoma

  • Squamous Cell Carcinoma Of Lung

  • Squamous Cell Lung Carcinoma

  • Epidermoid Cell Carcinoma Of The Lung

  • Squamous Cell Lung Cancer
Squamous Cell Carcinoma, Head And Neck

  • Squamous Cell Carcinoma Of The Head And Neck

  • HNSCC

  • Head And Neck Squamous Cell Carcinoma

  • Squamous Cell Carcinoma Of Lip

  • Squamous Cell Carcinoma, Head And Neck, Somatic

  • Carcinoma Of The Head And Neck

  • Squamous Cell Carcinomas Of Head And Neck

  • Scchn

  • Squamous Cell Carcinoma Of The Hypopharynx

  • Squamous Cell Carcinoma Of The Oropharynx

  • Squamous Cell Carcinoma Of Salivary Glands

  • Squamous Cell Carcinoma Of The Nasal Cavity And Paranasal Sinuses

  • Squamous Cell Carcinoma Of The Nasal Cavity And Sinuses

  • Squamous Cell Carcinoma Of The Oral Cavity

  • Squamous Cell Carcinoma Of The Lip

  • Carcinoma, Squamous Cell Of Head And Neck

  • Lip Squamous Cell Carcinoma

  • Carcinoma, Squamous Cell, Head And Neck

  • Salivary Gland Squamous Cell Carcinoma

  • Cancer Of Head And Neck

  • Squamous Cell Carcinoma Of Oropharynx Nos
Esophageal Cancer

  • Esophageal Carcinoma

  • Carcinoma Of Esophagus

  • Esophageal Squamous Cell Carcinoma, Somatic

  • Esophageal Carcinoma, Somatic

  • Esophagus Cancer

  • Gastric Cardia Adenocarcinoma

  • Esophageal Neoplasms

  • Esophageal Cancer, Somatic

  • Cancer Of Esophagus

  • Cancer Of Oesophagus

  • Carcinoma Of Oesophagus

  • Ca Lower Third Oesophagus

  • Ca Middle Third Oesophagus

  • Malignant Neoplasm Of Distal Third Of Esophagus

  • Malignant Neoplasm Of Lower Third Of Oesophagus

  • Malignant Neoplasm Of Middle Third Of Oesophagus

  • Malignant Neoplasm Of Proximal Third Of Esophagus

  • Malignant Neoplasm Of Upper Third Esophagus

  • Malignant Tumor Of Abdominal Esophagus

  • Malignant Tumor Of Distal Third Of Esophagus

  • Malignant Tumor Of Proximal Third Of Esophagus

  • Malignant Tumor Of The Middle Third Of The Esophagus

  • ESCR

  • Aerodigestive Tract Cancer

  • Escc

  • Esophageal Squamous Cell Carcinoma

  • Cancer, Esophageal

  • Malignant Neoplasm Of Esophagus

  • Squamous Cell Carcinoma Of Esophagus

  • Malignant Neoplasm Of Middle Third Of Esophagus
Lung Cancer Susceptibility 3

  • Lung Adenocarcinoma

  • Adenocarcinoma Of Lung

  • LNCR3

  • Adenocarcinoma Of Lung, Susceptibility To

  • Bronchogenic Lung Adenocarcinoma

  • Nonsmall Cell Adenocarcinoma

  • Adenocarcinoma Lung

  • Lung Adenocarcinomas

  • Non-Small Cell Adenocarcinoma
Inherited Cancer-Predisposing Syndrome

  • Hereditary Cancer-Predisposing Syndrome
Bap1 Tumor Predisposition Syndrome

  • Bap1-Related Tumor Predisposition Syndrome

  • Common Syndrome

  • Bap1 Cancer Syndrome

  • Bap1-Tpds

  • Cutaneous/Ocular Melanoma, Atypical Melanocytic Proliferations, And Other Internal Neoplasms

  • Tumor Predisposition Syndrome

  • Tumor Susceptibility Linked To Germline Bap1 Mutations

  • Cutaneous/Ocular Melanoma, Atypical Melanocytic Proliferations, Other Internal Neoplasms

  • Tumor Predisposition
Diseases Alias
Waldenstroem'S Macroglobulinemia

Waldenstroem'S Macroglobulinemia

Waldenstroem'S Macroglobulinemia

Macroglobulinemia Of Waldenstrom

Lymphoplasmacytic Lymphoma With Igm Gammopathy

Lymphoplasmacytic Lymphoma

Waldenstroem'S Macroglobulinemia

Waldenstroem'S Macroglobulinemia

Macroglobulinemia Of Waldenstrom

Lymphoplasmacytic Lymphoma With Igm Gammopathy

Lymphoplasmacytic Lymphoma

Related Agents

  • Approval
  • Clinical Phase
  • Pre-clinical Phase

Approval

Bioactive Molecules (3)
Cat. No. Product Name Effect
Purity Rare Diseases
HY-10260 Vandetanib 99.85% Yes
HY-10260B Vandetanib hydrochloride / Unkown
HY-10260A Vandetanib trifluoroacetate / Unkown

Clinical Phase

Bioactive Molecules (2)
Cat. No. Product Name Effect
Purity Phase
HY-15196 TAK-285 Inhibitor 98.99% Phase 1
HY-18957B Lifirafenib maleate Inhibitor / Phase 1

Pre-clinical Phase

Bioactive Molecules (49)
Cat. No. Product Name
Effect
Purity
Rare Diseases
HY-P0221 PACAP (1-38), human, ovine, rat Inducer 99.99% Unkown
HY-116624 MAZ51 99.96% Unkown
HY-156112 LM2I Activator 99.78% Unkown
HY-13464 ALK-IN-1 Inhibitor 99.94% Unkown
HY-78869 Mutated EGFR-IN-1 99.90% Unkown
HY-138627A AST5902 trimesylate Inhibitor 98.75% Unkown
HY-135805B (Rac)-JBJ-04-125-02 acetate 96.58% Unkown
HY-100962 (E)-AG 99 Inhibitor 98.36% Unkown
HY-135805A (Rac)-JBJ-04-125-02 Inhibitor / Unkown
HY-19617 EGFR-IN-1 Inhibitor / Unkown
HY-19617A EGFR-IN-1 hydrochloride Inhibitor / Unkown
HY-158310 SOS1/EGFR-IN-1 Inhibitor 99.54% Unkown
HY-19617B EGFR-IN-1 TFA Inhibitor 99.38% Unkown
HY-21292 SU5214 Inhibitor 98.0% Unkown
HY-125841 EGFR mutant-IN-1 Inhibitor / Unkown
HY-141486 (Rac)-PROTAC PARP/EGFR ligand 1 / Unkown
HY-168968S ZJY-54 Inhibitor / Unkown
HY-10260S Vandetanib-d6 / Unkown
HY-10260S1 Vandetanib-d4 / Unkown
HY-10260S2 Vandetanib-13C6 / Unkown
HY-12299G WH-4-023 (GMP) Inhibitor / Unkown
HY-124398 GL-1196 Inhibitor / Unkown
HY-141486A PROTAC PARP/EGFR ligand 1 / Unkown
HY-149695 EGFR-IN-91 Inhibitor / Unkown
HY-153744 JGK-068S Inhibitor / Unkown
HY-153856 TAS2940 Inhibitor / Unkown
HY-153856A TAS2940 fumarate Inhibitor / Unkown
HY-155227 ALK/EGFR-IN-1 / Unkown
HY-155227S ALK/EGFR-IN-1-d5 / Unkown
HY-156470 Multi-kinase-IN-6 / Unkown
HY-157402 Topoisomerase II/EGFR-IN-1 / Unkown
HY-162575 Anticancer agent 231 / Unkown
HY-163434 PRMT5/EGFR-IN-1 Inhibitor / Unkown
HY-163726 GLUT1/EGFR-IN-1 99.75% Unkown
HY-168433 LSD1/EGFR-IN-1 Inhibitor / Unkown
HY-168492 TrxR/EGFR-IN-1 / Unkown
HY-169428 EGFR-IN-138 / Unkown
HY-170543 Dual Galectin-3/EGFR-IN-1 / Unkown
HY-173520 EGFR/HDAC-IN-1 Inhibitor / Unkown
HY-175009 MRC-G-001 / Unkown
HY-181061 COX/5-LO-IN-2 / Unkown
HY-181775 VEGFR-2/c-Met/EGFR-IN-1 Inhibitor / Unkown
HY-181923 IMP-Zn / Unkown
HY-183090 EGFR/VEGFR2-IN-13 / Unkown
HY-183373 EGFR/PARP-1-IN-1 Inhibitor / Unkown
HY-184116 A2AR/EGFR-IN-1 / Unkown
HY-18957A rel-Lifirafenib Control / Unkown
HY-P0221A PACAP (1-38), human, ovine, rat TFA Inducer / Unkown
HY-W291369 Crotonamide / Unkown
Bioactive MoleculesInhibitory Antibodies (4)
Cat. No. Product Name
Effect
Purity
Rare Diseases
HY-P99892 Serclutamab 99.97% Unkown
HY-P99715 Losatuxizumab Inhibitor 99.44% Unkown
HY-P992138 Vadalentamig Inhibitor / Unkown
HY-P990408 Anti-ERBB1/EGFR/HER1 Antibody Inhibitor / Unkown